MedTrace Logo

TLESR-impedance Study in Patients

NCT00743444 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2013-07-22

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare frequency and content of reflux episodes in patients with gastroesophageal reflux disease.

Conditions

  • Reflux Episodes

Interventions

DRUG

AZD3355

65 mg capsules, oral, 3 single doses

DRUG

Placebo

capsules, oral, 3 single doses

Sponsors & Collaborators

Principal Investigators

  • Eva Ersdal, PhD · AstraZeneca R&D, Mölndal, Sweden

  • Daniel Sifrim, MD, PhD · Center for Gastroenterological Research, Belgium

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-02-29
Completion
2008-02-29

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743444 on ClinicalTrials.gov